Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC TAK-875 1000413-72-8 10mM (in 1mL DMSO)
Supplier: Apexbio Technology LLC A83395.1
TAK-875 (CAS 1000413-72-8) is a selective orally bioavailable agonist targeting G-protein-coupled receptor 40 (GPR40) a receptor primarily expressed in pancreatic -cells Activation of GPR40 enhances glucose-dependent insulin secretion via free fatty acid signaling In vitro assays demonstrate that TAK-875 exhibits potent agonistic activity toward human GPR40 with minimal cross-reactivity against other related receptors in the free fatty acid receptor family (EC50 10 M) Additionally in vivo studies in glucose-intolerant obese Wistar rats have shown that oral administration of TAK-875 improves glucose tolerance and stimulates insulin release Clinically TAK-875 has been explored as a glucose-dependent insulin secretagogue with once-daily oral dosing potential
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction